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ABSTRACT
We describe a semiquantitative RT-PCR protocol optimized in
our laboratory to extract RNA from as little as 10,000 cells and
to measure the expression levels of several target mRNAs from
each sample. This procedure was optimized on the human
erythroleukemia cell line TF-1 but was successfully used on
primary cells and on different cell lines. We describe the
detailed procedure for the analysis of Bcl-2 levels. Aldolase A
was used as an internal control to normalize for sample to
sample variations in total RNA amounts and for reaction
efficiency. As for all quantitative techniques, great care must be
taken in all optimization steps: the necessary controls to ensure
a rough quantitative (semi-quantitative) analysis are described
here, together with an example from a study on the effects of
TGF-b1i nT F - 1c e l l s .
INTRODUCTION
Reverse Transcription-Polymerase Chain Reaction (RT-PCR)
is a highly sensitive and specific method useful for the
detection of rare transcripts or for the analysis of samples
available in limiting amounts (1,2). In most cases, when RNA
analysis is required, a qualitative study is not sufficient to
deliver a satisfactory answer. A common question is the
quantification of specific RNA transcripts and the detection of
any variation in their expression levels under different
experimental conditions. We have often faced the problem of
detecting poorly expressed transcripts, as well as that of
handling small amounts of unique samples, such as primary
hematopoietic cells (3,4) or tumor biopsies from human
patients (5-7). When studies are performed in human primary
models or in established and transformed cell lines in
conditions requiring expensive reagents, analysis has to be
performed with a sensitive but reliable technique because only
a limited number of experiments can be run on each sample. A
number of protocols and improved PCR techniques are now
available, which will be discussed in the present manuscript,
but these are not all easily accessible to a standard laboratory
and have pitfalls together with the advantages for which they
were created. Although reproducibility is always an essential
requirement, extreme accuracy may not be: in most studies the
focus is not to measure minor changes or the exact number of
molecules, but an increase or decrease by at least 1.2-fold in
expression levels. Hence, despite the greater accuracy of
recently developed techniques, semi-quantitative methods are
still widely used and appropriate for many puposes. Here we
describe the standard procedure, optimized in our laboratory, to
assess Bcl-2 levels with Aldolase A as an internal control, and
all the necessary controls to ensure a quantitative analysis.
Examples of the analyses of multiple markers and of the data
obtained are shown.
MATERIALS AND METHODS
RNA extraction
RNA extractions were carried out with the RNeasy mini kit
(Quiagen, Hilden, Germany), according to the manufacturer’s
instructions. We normally used 2 x 10
5 cells, but cell numbers
ranging from 1 x 10
4 t o2x 1 0
6 were successfully utilized. The
following protocols are optimized on the human
eryhtroleukemia TF-1 cell line (8), and were tested with
Phytohemoagglutinin-activated lymphocytes, but different cell
lines, primary hematopoietic cells and tumor biopsies were also
used successfully. Samples were vortexed for 1 min to shear
genomic DNA before loading onto the RNeasy mini columns,
and then eluted in a minimum volume of 30 mla n dam a x i m u m
volume of 2 x 50 ml RNAse-free water. RNA obtained with this
procedure was essentially free of genomic DNA. When using
different extraction procedures, or working with tissue
samples, a DNAse I treatment, followed by phenol extraction
and ethanol precipitation, was applied to remove traces of
contaminating DNA (9).
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Reverse Transcription
RNA obtained from 20,000 cells was reverse transcribed in the
presence of 5 mM MgCl2,1 XP C RB u f f e rI I ,1m Md N T P s ,2 5
u MuLV Reverse Transcriptase, 1 u RNAguard Ribonuclease
inhibitor (Amersham Pharmacia Biotech, Uppsala, Sweden),
2.5 mM Random hexamers in a final reaction volume of 20 ml.
All reagents were from PE Applied Biosystems except when
otherwise specified. Reactions were carried out at 42°C for 30
minutes in a Gene Amp PCR system 9600 (PE Applied
Biosystems), followed by a 10 minute step at 99°C to denature
the enzyme, and then by cooling to 4°C.
PCR
a) Standard reaction for Bcl-2
Two ml of cDNA products were amplified with 1 unit of Ampli
Taq Gold (PE Applied Biosystems) in the buffer provided by
the manufacturer which contains no MgCl2, and in the presence
of the specific primers for Bcl-2, together with the Aldolase-A
primers (6), used as an internal control as described below. The
amount of dNTPs carried over from the reverse transcription
reaction is fully sufficient for further amplification. Reactions
were carried out in the Gene Amp PCR system 9600. A first
cycle of 10 minutes at 95°C, 45 seconds at 65°C and 1 minute
at 72°Cw a sf o l l o w e db y4 5s e c o n d sa t9 5 °C, 45 seconds at
65°C and 1 minute at 72 °C for 30 cycles (see below). The
conditions were chosen so that none of the RNAs analyzed
reached a plateau at the end of the amplification protocol, i.e.
they were in the exponential phase of amplification, and that
the two sets of primers used in each reaction did not compete
with each other (see below for a description of the necessary
controls and determination of the specific parameters). Each set
of reactions always included a no-sample negative control. We
usually performed a negative control containing RNA instead
of cDNA to rule out genomic DNA contamination. We have
tested Taq polymerases from different sources, but have
standardized our protocol with AmpliTaq Gold (PE Applied
Biosystems).
b) Primer selection and determination of Tm
Our primers were synthesized by Amersham Pharmacia
Biotech. The sequence was determined using the software
Primer 3 (developed by Steve Rozen, Helen J. Skaletsky, 1996,
1997) available on-line at http://www-genome.wi.mit.edu.
Primers were always chosen according to the following
parameters: length between 18 and 25 bases, optimal 20-22
bases; Tm comprised between 57 and 65°C, optimal Tm 60-
62°C; length of amplification product between 200 and 500 bp,
so as not to overlap with the 176 bp Aldolase A amplification
product. Occasionally, the primers were selected manually
according to the following criteria: C+G content, >60 %;
repetitive sequences, absent; repetitive bases, stretches of >3
identical bases (such as poly Ts) were normally avoided
(although 4 was shown to work); sequence, perfectly
homologous to the RNA of interest and so that the 3' end base
was preferably G or C. To determine specificity, all sequences
were compared with the Genbank using the program Blast
available at the National Center for Biotechnology Information
website (www.ncbi.nlm.nih.gov). When both primer sequences
showed homology to the same gene, different from that of
interest, they were discarded. Moreover, when possible, it is
advisable to select the PCR primers in such a way that the 5'
and the 3' primers span different exons, so that the
amplification product obtained from the cDNA would be of
different length from that obtained from any contaminant
genomic DNA comprising intronic sequences.
The following primers were used: Bcl-2 5’-CGACTT
CGCCGAGATGTCCAGCCAG-3’ (Tm 63.5°C), and 5’-
ACTTGTGGCCCAGATAGGCACCCAG-3’ (62°C); Aldolase
A A25, 5’-CGCAGAAGGGGTCCTGGTGA-3’ (59°C) and
H20, 5'-CAGCTCCTTCTTCTGCTCCGGGGT-3’ (62.2°C).
The Tms indicated in brackets were calculated according to the
formula reported by Sambrook et al. (9), see below for
comments. Bcl-2 yielded an amplification product of 388 bp
and Aldolase A of 176 bp. See (10) and (11).
c) Primer concentration.
Each primer was used in a concentration range of 0.05 to
0.3 mM. Lower concentrations may be limiting, in which case
the amplification would not be quantitative, whereas higher
concentrations may leave a large amount of unused primers
which could give rise to non-specific amplification products. In
our system, a concentration of 0.06-0.15 mM was usually
optimal. We optimized Bcl-2 with 0.15 mM of each of the two
Bcl-2-specific primers and 0.06 mM of each Aldolase A-
specific primer. The higher concentration used for Bcl-2 is due
to an attempt to favor amplification of Bcl-2, which is
expressed at lower levels than Aldolase A.
d) Determination of optimal MgCl2 concentration
Determination of the optimal concentration for each primer set
was performed using different MgCl2 concentrations in the
standard PCR reaction conditions (see below) and by adjusting
the water volume consequently. We normally tested the
following MgCl2 concentrations: 1, 1.5, 2, 3 and 5 mM. The
products were run on an agarose gel (see below) to choose the
condition that gave the highest yield and specificity. Bcl-2
amplification gave the best results in 1 mM MgCl2 (Fig 1).
e) Determination of cycling parameters
The annealing temperature was calculated as described above.
The standard program comprised a cycle of 10 minutes at
95°C, 45 seconds at 65°Ca n d1m i n u t ea t7 2 °C, followed by
45 seconds at 95 °C, 45 seconds at 65 °Ca n d1m i n u t ea t7 2 °C
for a number of cycles to be determined (30 for Bcl-2). It is
important to select the appropriate number of cycles so that the
amplification product is clearly visible on an agarose gel (see
below) and can be quantified, but also so that amplification is
in the exponential range and has not reached a plateau yet. The
optimal number of cycles has to be in the same range for the
specific RNA of interest (i.e. Bcl-2) and the control, in this
case Aldolase A, so that both can be measured on the same gel.
When the annealing temperature of the two primer sets was
different, annealing temperatures ranging between the optimal
temperature of each primer set were tested.Marone et al.
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f) Control for competition between primer sets
To determine whether the selected conditions are suitable for
semiquantitative RT-PCR with both primer sets (Bcl-2 and
Aldolase A) at the same time, we performed a competition
control, by amplifying the same sample at the same time in the
presence of the specific primers for Bcl-2, the internal control
Aldolase A, and both sets together. The samples were then run
on the same agarose gel for quantitation. When competition
was detected, different reaction conditions were tested (see
Results and Discussion).
Gel Electrophoresis
The PCR products were loaded onto Ethidium Bromide-
stained, 1 to 2 % (depending on the size of the amplification
products) agarose gels (1 % for Bcl-2) in TBE (9). A 1 kbp
DNA ladder molecular weight marker (Life Technologies,
Rockville, MD) was run on every gel to confirm expected
molecular weight of the amplification product.
Acquisition of gel images and quantitative
analysis
Images of the RT-PCR ethidium bromide-stained agarose gels
were acquired with a Cohu High Performance CCD camera
(Cohu Inc. San Diego, CA) and quantification of the bands was
performed by Phoretix 1 D (Phoretix International Ltd.,
Newcastle upon Tyne, UK). Band intensity was expressed as
relative absorbance units. The ratio between the sample RNA
to be determined and Aldolase-A was calculated to normalize
for initial variations in sample concentration and as a control
for reaction efficiency. Mean and standard deviation of all
experiments performed were calculated after normalization to
Aldolase A.
Further control: hybridization of PCR products
with specific primers
When the PCR yield is very low and hence barely detectable or
not visible at all on agarose gel, or when non-specific
amplification products cannot be eliminated, it may be
necessary to blot the agarose gel containing the PCR
amplification products and hybridize it with a labeled specific
probe. This can either be the cDNA (obtained by cloning or by
PCR) or a specific oligonucleotide. This step is normally not
required but we had to perform it with a few markers which
were otherwise difficult to detect or quantify (3-6).
RESULTS AND DISCUSSION
When choosing a quantitative or semi-quantitative protocol to
determine RNA expression levels by RT-PCR, many
parameters must be taken into consideration (12). These
include: 1) feasibility in the laboratory; 2) necessity to study
different markers in the same sample; 3) availability of sample;
4) accuracy required for the specific application (i.e. need to
measure the specific number of RNA molecules or rather rough
variations in RNA levels). Relatively accurate methods have
been developed, such as competitive PCR (MIMIC) or real-
time PCR based on the use of fluorogenic probes. The MIMIC
technique requires an internal competitor that has to be
specifically designed and then constructed for each specific
RNA to be studied (13,14). An amplification curve with the
internal competitor is then built for each sample. Quantification
is rather accurate, but this technique requires a relatively large
amount of cDNA and a large number of amplification reactions
per sample and moreover, requires intensive initial work when
different RNAs have to be analyzed and hence different mimic
competitors need to be constructed. The PCR techniques that
were initially devised (competitive, non-competitive, etc.) are
all based on an “end point” measurement, that occurs when the
PCR reaction is completed. Real-time PCR is a very promising
quantitative method that is based on the concept of monitoring
the PCR reaction in the thermal cycler as it progresses. A
number of real-time methods have been devised (15,16,17),
which require a dedicated instrument. Although this technique
undoubtedly has a number of advantages, especially in terms of
accuracy, it is not easily available to the standard laboratory
and may be cumbersome to set up when used as only one of
many techniques running in the laboratory. Another interesting,
recently devised method, is the single-tube PCR, which permits
reverse transcription and PCR in the same tube using the tTh
enzyme (18). This is a very convenient method when a single
RNA marker has to be analyzed in a large number of samples.
On the other hand, assaying several RNAs on the same sample,
we preferred to work on the same cDNA product in order to
reduce the variability due to the reverse transcription reaction.
For a rather comprehensive discussion of advantages and
pitfalls, see a recent review by W. M. Freeman et al. (12). In
our laboratory we have successfully utilized a semi-
quantitative PCR method employing Aldolase A as an internal
control in a number of systems and different types of samples
(3-7). This method is based on the use of an internal control,
which is a housekeeping gene (19,11) and hence on the
assumption that the experimental conditions do not alter the
expression levels of the selected control RNA. Since
determination of RNA concentration is often inaccurate, and
consumes a considerable amount of sample, we chose to work
with a fixed number of cells (2,000 cells per PCR reaction). In
our conditions Aldolase A content did not vary significantly
( 2 0 )w i t h i nt h es a m et y p eo fs a m p l e( i . e .t h es a m ec e l ll i n eo r
the same tissue type). We describe here the controls that were
performed to establish the conditions to amplify Bcl-2 RNA in
the human cell line TF-1, and that need to be established
whenever studying a new marker or a new system in order for
the data to be at least roughly quantitative.
Reaction conditions in the Reverse Transcription step are
mostly dependent on the enzyme and the primers of choice.
Whereas other protocols require use of specific primers, we
prefer to reverse transcribe the total RNA population with
random hexamers so that different PCR analyses could be
performed on the same cDNA sample. Alternatively, a poly T
primer could be used to amplify RNAs from their 3’ tail, but in
our hands this approach gave a lower yield than that with
random hexamers.
A number of parameters can be varied in the PCR step and areMarone et al.
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extremely important for the reaction to be quantitative. A
variety of thermostable polymerases are now available on the
Fig. 1: Effect of different MgCl2 concentrations in the PCR
reaction. Analysis was performed on the human
erythroleukemia cell lime TF-1. Bcl-2 amplification was
optimal at 1 mM MgCl2 and decreased gradually at higher
concentrations. The intensity of the Aldolase A amplification
product did not change significantly. Ald A, Aldolase A.
market. In the past “hot-start” was often employed to avoid
immediate start of transcription before denaturation and proper
annealing of the primers. In recent years an easy alternative has
become available from different manufacturers, by the addition
of “blocking” antibodies to the polymerase, which keep the
polymerase inactive till it is heated to 92-95°C for at least 10-
12 minutes. The enzyme is hence not active during the time
required to set up the reactions. Moreover, use of this enzyme
can sometimes increase specificity.
Selction of the internal control RNA is also critical. Other
control RNAs were tested (such as GAPDH, or actin), but most
of the best known housekeeping genes are expressed at very
high levels, hence their amplification profile reaches a plateau
much earlier than the relatively low abundant RNAs we
studied. Moreover, suitable conditions for amplification of
Aldolase A were very flexible, ranging from a MgCl2
concentration of 1 to 5 mM (Fig. 1), 27 to 32 cycles (Fig. 2),
and an annealing temperature of 55 to 65°C, which made this
gene the ideal control, easily adaptable to combination with
most other primer sets.
MgCl2 is an essential factor for the Taq polymerase to function,
in a range of 1-5 mM, but efficiency of amplification with
specific primers is strictly sequence-dependent. As shown in
Fig.1, Bcl-2 worked best at 1-2 mM MgCl2, whereas the yield
of Aldolase A did not change at the concentrations tested (Fig.
1). Any primer set behaves differently, and a narrower
concentration range (for example 1, 1.5, 2, 2.5, 3 mM) can be
tested, if necessary. As a matter of fact we have come across
primer sequences that gave optimal amplification at 1.5 mM
but no amplification at all at 1 nor at 2 mM MgCl2 (21). The
calculated Tms differ according to the formula chosen for its
calculation and number of different formulas have actually
been described in the literature. We normally refer to the Tm
calculated by the program Primer 3 (see Materials and
M e t h o d s )o rt ot h eT m calculated by Amersham Pharmacia
Biotech and provided with each oligonucleotide data sheet. The
actual annealing temperature (Tann) utilized in the PCR can be
up to 2-5°C higher than the calculated Tm. Alternatively, we
referred to the formula described by
Fig. 2: Determination of the exponential range of
amplification for Bcl-2 and Aldolase A. The analysis was
performed in 1 mM MgCl2 a t6 5 ° C .T h ei n t e n s i t yo ft h eB c l - 2
amplification product increased up to 36 cycles, whereas
Aldolase A(Ald A) reached a plateau at 33 cycles.
Sambrook et al. (9): Tm = 58+ 0.4 * (% G + C) -500/l , in
which l is the oligo length. In this case, the optimal Tann was
normally about 3-5°C higher than the calculated Tm.O n l yi na
few particular cases we found it necessary to test different
temperatures (slightly above and below the calculated Tann).
Another parameter to be analyzed thoroughly is the number of
amplification cycles to perform. It is not sufficient to visualize
the amplification product on a gel. It is well known that
amplification is initially exponential but reaches a plateau
when the activity of the enzyme declines and when any of the
reagents become limiting in the reaction. At plateau, RNAs
initially present at high levels may give products of equal
intensity to low abundant RNAs. In our experiments we tested
a number of cycles ranging from 24 to 36 (Fig 2). Fig. 2 shows
that whereas Bcl-2 intensity increased up to 36 cycles, no
increase could be seen in Aldolase A at more than 33 cycles,
i.e. it had already reached a plateau. Another problem that we
have often encountered is non-predictable cross-hybridization
that occurs when two or more primer sets are enclosed in the
reaction.Marone et al.
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Fig. 3: Control for competition between different primer sets. Reactions were performed in the same conditions for lanes 1, 2
and 3. Lane 1 contained the Aldolase A primer set only, lane 3 the Specific primers for the target RNA, and lane 2 both primer sets.
In the selected conditions (1 mM MgCl2, 65°C, 30 cycles) Bcl-2 and Aldolase A did not compete (left panel). The middle panel
shows an example in which the specific primers for the target RNA (p27) competed with the Aldolase A primers (left, 2 mM
MgCl2). The right panel shows the same samples as in the middle panel: substitution of 2 mM with 3 mM MgCl2, eliminated
competition, i.e the intensity of the p27 band did not change when the Aldolase A primers where included in the reaction (lane 2).
Ald A, Aldolase A.
T/C 1 5.8 1 1 5.8 1 1 1 0.7 1 1 1.3 1 1 1.6
Fig. 4: Example of analyses performed on different target RNAs in the same set of samples: effect of TGF-b b b b1o nT F - 1c e l l s .
Lane 1 is control TF-1 cells, lane 2 treatment with TGF-b1, lane 3 treatment with anti-TGF-b1. In all panels, the upper band is the
target and the lower band is the amplification product of Aldolase A. T/C indicates the relative level of the target amplification
product (T) over the Aldolase A internal control (C) after normalization to the control sample, i.e. it expresses the change in folds
with respect to the untreated control (lane 1).
Quantitation has to performed on the individual amplification
products obtained with single primer sets, and only if the
amplification products obtained with each separate primer set
had the same intensity as that obtained with both primer sets
together, were the conditions considered as optimal (Fig.3, left
panel). Otherwise, when competition showed as a decrease in
intensity of the target RNA in the presence of Aldolase A (Fig
3, right panel), different reaction conditions were tested (in
terms either of MgCl2 concentration or annealing temperature,
or both, see above). We show in Fig. 3 how Bcl-2 and Aldolase
A did not compete when combined at 30 cycles in 1 mM
MgCl2. On the other hand, we show as an example that p27
primers did compete with Aldolase A, and that the
amplification product for p27 was greatly reduced in the
presence of the Aldolase A primers when the reaction was
performed in 2 mM MgCl2. When the MgCl2 concentration
was increased to 3 mM competition was completely eliminated
(Fig. 3, right panel). We have seen so far that a number of
parameters are very critical in performing a duplex PCR
reaction in condition such that the amplification is roughly
quantitative. As a consequence, the probability that more than
two primer sets can be optimized in identical reaction
conditions is very low. Therefore, it may be very cumbersome
to establish optimal reaction conditions for multiple sets of
primers at the same time (multiplex PCR). It may be easier and
safer to perform separate reactions for each target RNA. When
reaction conditions are optimized, quantification becomes
reliable (22,23). When performing reactions on different sets of
samples in the same experimental conditions, variability after
normalization to Aldolase A was never greater than 15% in our
hands. In our case, when working with the smallest number of
cells (10,000) we could only perform at most 5 PCR reactions.
When working with larger samples, the number of target RNAs
that can be analyzed is almost unlimited. We show in Fig. 4 an
example of RT-PCR analysis performed on the
erythroleukemia cell line TF-1 in different experimental
conditions. We have previously shown that TGF-b1 has anti-
differentiating properties in hematopoietic progenitors (4). We
measured the RNA levels of some common markers of
differentiation of hematopoietic cells (Bcl-2, CD34, c-myb, a-Marone et al.
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globin, and lysozyme) following exposure to TGF-b1 or anti-
TGF-b1. TF-1 cells were exposed to 5 ng/ml TGF-b1o rt o
20mg/ml anti-TGF-b1 blocking antibodies for 48 hours (24). In
this example Bcl-2 levels did not change significantly and
CD34 increased by 5.8-fold in the presence of TGF-b1,
indicating a shift of the cells to a more primordial state. c-myb
decreased to 0.7-fold, a-globin increased by 1.3-fold and
lysozyme by 1.6-fold when TGF-b1 was depleted with
blocking antibodies. These values are the mean of three
independent experiments, in which the deviation was always
comprised between 12 and 15 %. When the calculated value
(T/C, in the figure) was different from the corresponding
control by less than 20%, it was considered as equal to 1.
Our experiments confirmed that semiquantitative RT-PCR
provides reliable information as long as the proper controls are
all performed correctly. The protocols we have described have
been reproduced on different types of samples and different
target RNAs and some of the analyses were also confirmed by
Western blotting or by flow cytometry and produced analogous
information (4,5,6,24).
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